A patient with thrombocytosis (excess platelets) experiences increased risk of vascular occlusion. Why does platelet aggregation cause this heightened occlusion risk?

💡 Explanation

Platelet aggregation initiates a cascade that forms bulky clumps. Because these aggregates physically obstruct blood flow in smaller vessels, vascular occlusion risk increases; therefore, the correct answer is vessel blockage, rather than fibrinolysis, nitric oxide production, or permeability reduction.

• If a genetically modified T-cell expressing a chimeric antigen receptor (CAR) encounters a tumor cell displaying the target antigen, which consequence follows in the tumor microenvironment?
• Why does interstitial fluid accumulate in lymphedema following lymph node removal?
• What distinguishes proteasomal degradation from chaperone-mediated autophagy in intracellular protein clearance?
• Why does chronic exposure during allergen-specific immunotherapy gradually reduce allergic responses in sensitized individuals?
• Why does prolonged inflammation in melanocyte-stimulating hormone (MSH)-sensitive skin regions result in hyperpigmentation, rather than hypopigmentation, even if the initial inflammatory trigger fades?
• If a patient's cardiac preload suddenly decreases during rapid blood loss, which consequence follows related to cardiovascular hemodynamics?